Everhart Financial Group, Inc. Bristol Myers Squibb CO Transaction History
Everhart Financial Group, Inc.
- $1.05 Billion
- Q4 2025
A detailed history of Everhart Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Everhart Financial Group, Inc. holds 17,777 shares of BMY stock, worth $832,141. This represents 0.08% of its overall portfolio holdings.
Number of Shares
17,777
Previous 13,795
28.87%
Holding current value
$832,141
Previous $622,000
33.76%
% of portfolio
0.08%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,709Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...